✦ LIBER ✦

Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib

✍ Scribed by C. Cauchi; N. Somaiah; P. F. Engstrom; S. Litwin; M. Lopez; J. Lee; M. Davey; B. Bove; M. von Mehren

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nilotinib in patients with GIST who fail

✍ Kyu-pyo Kim; Min-Hee Ryu; Changhoon Yoo; Baek-Yeol Ryoo; Dae Ro Choi; Heung Moon 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 254 KB

Nilotinib in the treatment of advanced g

✍ M. Montemurro; P. Schöffski; P. Reichardt; H. Gelderblom; J. Schütte; J.T. Hartm 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 156 KB

PCN18 ECONOMIC EVALUATION OF SUNITINIB V

✍ Teich, N; Hashizume, C; Follador, W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Regorafenib: A Guide to Its Use in Advan

✍ Lyseng-Williamson, Katherine A. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 253 KB

The outcome and predictive factors of su

✍ Piotr Rutkowski, Elżbieta Bylina, Anna Klimczak, Tomasz Świtaj, Sławomir Falkows 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 248 KB

131 Pharmacodynamic analysis of apoptosi

✍ D. Davis; H. Choi; H. Macapinlac; P. Pisters; C. Charnsangavej; R. Benjamin; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB